Literature DB >> 19928754

Class I phospho-inositide-3-kinases (PI3Ks) isoform-specific inhibition study by the combination of docking and molecular dynamics simulation.

Ming Han1, John Z H Zhang.   

Abstract

The combination of docking and molecular dynamics simulation is used to explain the isoform-specific selectivity between PI3Kalpha and PI3Kgamma, which are two lipid kinases in the class I PI3Ks. The protein flexibility is incorporated in docking the ligands to the ensemble of representative structures extracted from a clustering analysis of the molecular dynamics simulation in explicit aqueous solution. The reported most potent PI3Kalpha inhibitor PIK-75 was studied, and we predicted three possible PIK-75-bound conformations for PI3Kalpha and two for PI3Kgamma. Comparative analysis between the PI3Kalpha and PI3Kgamma docking experiments indicates that the residue Trp780 and Asn782 in PI3Kalpha and the corresponding residues Trp812 and Glu814 in PI3Kgamma in the solvent-accessible region can confer the PI3Kalpha and PI3Kgamma isoform specificity. The predicted bound conformations are further studied in aqueous solution by molecular dynamics simulation. The work provides a possible effective pharmacophore model for PI3Kalpha inhibitor. The dynamic behaviors of the LY294002-bound PI3Ks are studied too.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19928754     DOI: 10.1021/ci900175n

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  12 in total

1.  Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity.

Authors:  Jinan Wang; Fangfang Wang; Zhengtao Xiao; Guowen Sheng; Yan Li; Yonghua Wang
Journal:  J Mol Model       Date:  2011-12-03       Impact factor: 1.810

2.  Definition of the binding mode of phosphoinositide 3-kinase α-selective inhibitor A-66S through molecular dynamics simulation.

Authors:  Xiaoli Bian; Wangqing Dong; Yang Zhao; Rui Sun; Wanjun Kong; Yiping Li
Journal:  J Mol Model       Date:  2014-03-16       Impact factor: 1.810

3.  Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases.

Authors:  Dima A Sabbah; Jonathan L Vennerstrom; Haizhen Zhong
Journal:  J Chem Inf Model       Date:  2010-10-25       Impact factor: 4.956

4.  Characterization of molecular recognition of phosphoinositide-3-kinase α inhibitor through molecular dynamics simulation.

Authors:  Yiping Li; Jiye Zhang; Delong He; Qi Liang; Yawen Wang
Journal:  J Mol Model       Date:  2011-08-26       Impact factor: 1.810

Review 5.  Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment.

Authors:  Xianbo Wu; Yihua Xu; Qi Liang; Xinwei Yang; Jianli Huang; Jie Wang; Hong Zhang; Jianyou Shi
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

6.  Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methods.

Authors:  Jo-Anne Pinson; Oleg Schmidt-Kittler; Jiuxiang Zhu; Ian G Jennings; Kenneth W Kinzler; Bert Vogelstein; David K Chalmers; Philip E Thompson
Journal:  ChemMedChem       Date:  2011-01-04       Impact factor: 3.466

7.  A multi-conformational virtual screening approach based on machine learning targeting PI3Kγ.

Authors:  Jingyu Zhu; Yingmin Jiang; Lei Jia; Lei Xu; Yanfei Cai; Yun Chen; Nannan Zhu; Huazhong Li; Jian Jin
Journal:  Mol Divers       Date:  2021-06-23       Impact factor: 3.364

8.  Structural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of β2-Adrenergic Receptor.

Authors:  Tao Liang; Yuan Yuan; Ran Wang; Yanzhi Guo; Menglong Li; Xuemei Pu; Chuan Li
Journal:  ACS Omega       Date:  2017-12-01

9.  Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma.

Authors:  Francesca Pedini; Gabriele De Luca; Federica Felicetti; Rossella Puglisi; Alessandra Boe; Maria Beatrice Arasi; Federica Fratini; Gianfranco Mattia; Massimo Spada; Simona Caporali; Mauro Biffoni; Alessandro Giuliani; Alessandra Carè; Nadia Felli
Journal:  Mol Oncol       Date:  2019-08-06       Impact factor: 6.603

10.  The Chinese herbal prescription JZ-1 induces autophagy to protect against herpes simplex Virus-2 in human vaginal epithelial cells by inhibiting the PI3K/Akt/mTOR pathway.

Authors:  Qingqing Shao; Tong Liu; Wenjia Wang; Qianni Duan; Tianli Liu; Lijun Xu; Guangying Huang; Zhuo Chen
Journal:  J Ethnopharmacol       Date:  2020-02-20       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.